IAG – UBS rates the stock as Sell – ShareCafe – ShareCafe

December 13, 2021
By Broker News | More Articles by Broker News
A change in covering analyst has led to a downgrade to Sell from Neutral on Insurance Australia Group from UBS as the company faces a number of challenges.
NRMA is being sued by the regulator for overcharging. The commercial business is undergoing remediation work. Most of IAG’s growth options have been divested in recent years. Positive covid impacts have now reversed due to supply chain issues driving a spike in claims.
Management is confident in achieving its 250m insurance profit target by FY24. In FY22 to date, price increases of 9% are apparently holding without major volume loss, the broker notes, but It is not clear this level of repricing is sufficient to restore double-digit margins.
Target falls to $4.20 from $5.35.
Sector: Insurance.
 
Target price is $4.20.Current Price is $4.36. Difference: ($0.16) – (brackets indicate current price is over target). If IAG meets the UBS target it will return approximately -4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
 
 
FNArena’s Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.






The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of Sequoia Asset Management Pty Limited who holds an Australian Financial Services Licence (Number: 341506)
Terms of Service | Privacy Policy | Contact | Advertise




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Truck.


We initiate coverage on Tamboran Resources with a 12-month target price of $1.10 – representing 520% upside from the current share price. The company provides investors with a pure exposure to the development of the world class unconventional gas resource located in the Beetaloo Sub basin in Australia’s Northern Territory. The drilling of 2 wells before the end of 2022, Amungee 2H and 3H, will provide significant visibility on the commerciality of the proposed EP 98 Pilot Development – both wells are fully funded with the company having a current cash balance of ~A$130million.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Flag.


 RareX Limited is an Australian Rare Earths company that has set its sights on becoming one of the largest light rare earth elements (LREEs) producers in Australia. The company’s flagship project is the Cummins Range deposit, a carbonatite deposit with a current 18.1Mt resource at 1.15% TREO (0.5% cut-off grade) that has significant potential for expansion. 
Recent exploration results have confirmed high-grade extensions at depth and along strike with an additional 30,000m drilling program commencing in the second quarter of FY2022. The companies scoping study suggests upside from phosphate and economic viability over the Life of Mine (LOM). 
We initiate on RareX Ltd with a A$0.12 price target – risked at 25% 




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Star.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Star.


This report looks at the results of a collaborative study Antisense undertook which looked at the largest protein expression database in Long COVID-19 patients who experienced neurologic symptoms well after the primary or acute SARS-CoV-2 infection was considered over (Groups 1 & 2, with 48 subjects Group 2 comprising a single patient from a different clinical site). The symptoms and others experienced by such patients result in a highly significant amount of illness, possibly more than all primary SARS-CoV-2 infections i.e COVID-19.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Heart.


Kazia Therapeutics (KZA) announced yesterday morning that paxalisib did not meet the threshold to move into stage 2 of the GBM AGILE clinical trial (NCT03970447). The study was an adaptive trial designed to assess the potential of new therapeutics to treat the highly aggressive brain cancer glioblastoma (GBM) in a cost-effective manner. Demonstrating efficacy in GBM is an extremely high hurdle as shown by the fact that there is only one approved drug for the disease, temozolomide, and it is only effective in 1/3 of patients.
Given the high nature of the hurdle, in our original initiating coverage report on KZA, we only gave paxalisib a small chance of returning a positive result from the overall study. That is the nature of drug development with one group estimating only 6% to 7% of new chemical entities that commence clinical trials reach launch (Dowden & Munro (2019) Nat Rev Drug Discov). The small percentage that do make it to launch, however, more than make up for the cash spent on those that don’t.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Car.


Terracom will report their FY2022 results in September 2022. In the last two months there have been a number of company announcements that have given us improved visibility on our earnings forecasts and valuation metrics so we have taken this opportunity to update our numbers.
With the combination of geopolitical factors in the northern hemisphere as well as disruption from other supply regions, we believe the visibility on export coal prices over the next 12 months has also improved since our March note.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Car.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Flag.


Lake Resources (LKE. ASX) – LKE has signed two non-binding MOU’s in the space of 10 days. Ford Company (Ford) has signed an MOU for ~25,000t/year and last week Hanwa, a Japanese commodity trader signed a MOU for up to 25,000t/year. Subject to execution, this is an amazing feat as Ford and Hanwa are prepared to enter into longer-term strategic partnerships with LKE. Commercial negotiations are still ongoing but are expected, especially if Ford & Hanwa inject new equity into LKE, to further de-risk the project financing & thus ensure LKE and Kachi are fully funded.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Flag.


TNG Ltd is an ASX-listed technology owner and developer of the world-class Mount Peake near-surface vanadiferous titanomagnetite deposit. To unlock value, TNG will concentrate ore from its central Northern Territory mine for processing through its patented TIVAN® process produce three premium quality revenue streams: hi-purity vanadium pentoxide (V2O5) for steel alloys and Vanadium Redox Flow batteries, a quality titanium pigment for paints and a premium steel input with >64%Fe iron ore fines.




SMSFBrokerFinancial Adviser
Please prove you are human by selecting the Star.


Two recent gravity surveys have considerably exceeded expectations and revealed potential for extensions to the existing MRE at Lake Throssell, plus a material growth opportunity at Lake Yeo. This reinforces the potential for a multi-decade, Tier-1 SOP production hub based around Lake Throssell.
TMG is currently completing work towards the PFS due early 2023, including drilling to start in Q3 2022, evaporation trials and permitting activities. Results from these programs will support the PFS and any future resource upgrade.
Benchmark SOP prices have risen to ~US$940/t due to recent geopolitical developments. The Oct 2021 Scoping Study assumed a SOP price of US$550/t and contained a sensitivity analysis showing every 10% increase in price drives a +$144m increase in the project NPV of $364m. The c.70% increase above the Scoping Study thus implies a project NPV of ~$1.4bn.

    SMSFBrokerFinancial Adviser

    Please prove you are human by selecting the Star.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Star.


    Despite the lower realised oil and gas price, which fell by 5.4% and 19.7% respectively in August, Calima managed to show improvement in its key business metrics.
    We expect higher production in November due to the contribution by the new Thorsby wells which will be drilled in August/September which will see Calima meet its 2021 production guidance of 4,500 boe/d.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Flag.


    WT Financial Group Limited (WTL) is a growing diversified financial services company, founded in 2010 and listed on the Australian Stock Exchange (ASX) in 2015. Its advice and product offerings are delivered primarily through a group of independent financial advisers operating as authorised representatives of WTL under its Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group) dealer group operations. It has around 275 advisers across more than 200 financial advice practices Australia-wide. It also operates a direct-to-consumer operation under its Spring Financial Group brand.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Plane.


    In May 2021, Corporate Connect analyst Marc Sinatra published a comprehensive research report on ASX-listed biotech Immutep Ltd (ASX: IMM). So impressed was he with IMM that Corporate Connect felt it imperative that a follow-up report be released placing a valuation on the company, because the market was not seeing the vast potential of eftilagimod alpha (efti).
    This follow-up report has been released today. Using comparables, after adding cash back to their EV estimate and dividing by the total number of issued shares, Corporate Connect now places the fair value of an Immutep share at $A2.20.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Flag.


    Phillips 66 (PSX) has entered into an agreement with NVX to acquire 77.9m new shares for US$150m (A$203m). PSX is the worlds largest producer of speciality petroleum coke a precursor for battery grade synthetic graphite anode materials found with an Enterprise Value of US$47.5Bn and assets of US$57Bn.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Car.


    PayGroup (PYG) delivers multi-country BPO services and cloud SaaS HCM solutions, assisting companies to manage employees in multiple, complex jurisdictions. The company has many growth opportunities, including new clients, new jurisdictions, new products, partner expansion, and new revenue sources. PYG’s scalable business model allows operating leverage and with savings from in-housing third party technology, support margin expansion.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Truck.


    OpenLearning (OLL) is a higher education technology company that operates a scalable online learning platform through a software-as-a-service (SaaS) business model and provides a global marketplace of high quality courses for learners of all levels. Its primary customers are education providers based in Australia and South-East Asia (primarily Malaysia). OLL started operations in Australia in 2012 and expanded to Malaysia in 2015, Singapore in 2018, and recently also Indonesia.




    SMSFBrokerFinancial Adviser
    Please prove you are human by selecting the Star.

    source

    Leave a Comment